Tuberculous meningitis Short course chemotherapy March short course trial therapy tuberculous meningitis patients diagnosis following cerebrospinal fluid test results cases Mycobacterium tuberculosis direct smear culture Lowenstein-Jensen medium positive detection anti-bacille Calmette-Guerin BCG antibodies enzyme-linked immunosorbent assay positive dosification adenosine deaminase activity positive addition cases diagnosis means autopsy findings diagnosis bacteriological analyses tissue body fluids administration antituberculous therapy patients last stage disease beginning treatment Sixteen percent patients months follow-up therapy neurological sequelae therapeutic regimen morbidity/mortality similar longer-course therapies latter regimen good acceptable therapeutic option treatment tuberculous meningitis 